Reviews cell-free DNA screening for selected fetal chromosomal conditions.
- Includes 1 listed test.
- Organizes related markers in one report for easier medical review.
- Uses private sample handling and clear laboratory reporting.
This NIPT prenatal screening test reviews cell-free DNA screening for selected fetal chromosomal conditions in one structured laboratory package. It supports clear, doctor-guided review without replacing clinical assessment.
SAR 790.00
Early Fetal Screening (NIPT), For Her, Laboratory PackagesReviews cell-free DNA screening for selected fetal chromosomal conditions.
A non-invasive prenatal screening test using cell-free DNA in maternal blood.
NIPT screens for selected fetal chromosomal conditions from a maternal blood sample. It can be performed from 10 weeks of pregnancy and provides a screening result, not a definitive diagnosis.
The results are intended to support an informed discussion with a qualified healthcare professional.
The report provides a screening classification for the conditions covered by the selected NIPT method. A high-risk, low-risk, or non-reportable result must be reviewed with an obstetrician or genetics professional.
NIPT is a screening test, not a diagnostic test. High-risk results require confirmatory diagnostic testing, and a low-risk result cannot exclude every fetal or genetic condition.
General note: Laboratory results must be interpreted with symptoms, history, medicine, pregnancy status when relevant, and the reference ranges shown on the report.
When can NIPT be performed?
It can generally be performed from 10 weeks of pregnancy.
Is NIPT diagnostic?
No. It is a screening test.
Do I need to fast?
No.
What happens after a high-risk result?
Review it promptly with your obstetrician or genetics professional to discuss confirmatory diagnostic testing.